Saved in:
| Main Author: | k1muk |
|---|---|
| Format: | Recurso digital |
| Language: | |
| Published: |
Zenodo
2025
|
| Online Access: | https://doi.org/10.5281/zenodo.17615504 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Ribosomal activation in TNBC resistance in vitro.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Raw read count lncRNA sequencing TNBC
by: van den Ende, Nadine, et al.
Published: (2026)
by: van den Ende, Nadine, et al.
Published: (2026)
Targeting NgR1/NogoA Signalling Enhances Natural Killer Cell Cytotoxicity and Alters Immune and Oncogenic Pathways in TNBC Cells
by: Tuğcan Korak, et al.
Published: (2026)
by: Tuğcan Korak, et al.
Published: (2026)
Investigation of TNBC metastatic potential following synergistic photodynamic therapy and chemotherapy
by: Jeanne Duong, et al.
Published: (2025)
by: Jeanne Duong, et al.
Published: (2025)
Unraveling the Complexities in TNBC Gene Interaction Networks Towards Better Therapeutics
by: Priyanga Paranthaman, et al.
Published: (2025)
by: Priyanga Paranthaman, et al.
Published: (2025)
Preliminary Research of Radiolabeled Atezolizumab for the Noninvasive Evaluation of TNBC PD‐L1 Expression In Vivo
by: Shuhua He, et al.
Published: (2024)
by: Shuhua He, et al.
Published: (2024)
Hierarchical Targeting of TREM2 + Myeloid Cells via Acid‐Triggered OMVs Reprogram Immunosuppression and Suppress Osteolysis in Bone‐Metastatic TNBC
by: Fanglu Chen, et al.
Published: (2026)
by: Fanglu Chen, et al.
Published: (2026)
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): PINK1.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Pristimerin Promotes Ubiquitination of HSPA8 and Activates the VAV1/ERK Pathway to Suppress TNBC Proliferation
by: Qin‐Wen Liu, et al.
Published: (2025)
by: Qin‐Wen Liu, et al.
Published: (2025)
HMGB3 Contributes to Anti‐PD‐1 Resistance by Inhibiting IFN‐γ‐Driven Ferroptosis in TNBC
by: Bo Luo, et al.
Published: (2024)
by: Bo Luo, et al.
Published: (2024)
Therapeutic targeting in androgen receptor-positive triple negative breast cancer (AR+ TNBC): THTPA.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in androgen receptor-negative triple negative breast cancer (AR- TNBC): HUNK.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): FGR.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Lupeol‐Loaded Liposomes: Triple‐Negative Breast Cancer (TNBC) Cytotoxicity and In Vivo Toxicological Evaluation
by: Daniel Crístian Ferreira Soares, et al.
Published: (2025)
by: Daniel Crístian Ferreira Soares, et al.
Published: (2025)
GPNMB is a novel binding partner of FGFR1 that affects tumorigenic potential through AKT phosphorylation in TNBC
by: Manar A. Elhinnawi, et al.
Published: (2024)
by: Manar A. Elhinnawi, et al.
Published: (2024)
Therapeutic targeting in androgen receptor positive triple negative breast cancer (AR+ TNBC): GRK3.
by: Mamoor, Shahan
Published: (2025)
by: Mamoor, Shahan
Published: (2025)
Targeting PKC as a Therapeutic Strategy to Overcome Chemoresistance in TNBC by Restoring Aurora Kinase B Expression
by: Bing Cheng, et al.
Published: (2025)
by: Bing Cheng, et al.
Published: (2025)
Correlation of Cell‐in‐Cell Structure With Prognosis in Solid Tumors—A Meta‐Analysis
by: Haoyi Zi, et al.
Published: (2025)
by: Haoyi Zi, et al.
Published: (2025)
γδ T Cell Infiltration Predicts the Prognosis of Lumbar Disc Herniation
by: Huijuan Wan, et al.
Published: (2025)
by: Huijuan Wan, et al.
Published: (2025)
Impact of the Microbiome on Onset and Prognosis of Oropharyngeal Squamous Cell Carcinoma
by: Saïf Eddine Zaidi, et al.
Published: (2025)
by: Saïf Eddine Zaidi, et al.
Published: (2025)
Four‐Pronged Nanomotor Strategy Achieves Efficient TNBC Treatment via Synergistic Chemo‐Photothermal‐Immune Therapy
by: Biao‐Qi Chen, et al.
Published: (2025)
by: Biao‐Qi Chen, et al.
Published: (2025)
ICIs Exceptional Long Response in TNBC : Addressing the Issue of Optimal ICIs Duration. Two Cases and Review of the Literature
by: Simone Rota, et al.
Published: (2025)
by: Simone Rota, et al.
Published: (2025)
Identification of a Novel Substrate for eEF2K and the AURKA‐SOX8 as the Related Pathway in TNBC
by: Xiaoya Wan, et al.
Published: (2025)
by: Xiaoya Wan, et al.
Published: (2025)
Influence of Social Vulnerability in Treatment and Prognosis of Squamous Cell Carcinoma of the Tongue
by: David J. Fei‐Zhang, et al.
Published: (2024)
by: David J. Fei‐Zhang, et al.
Published: (2024)
T Cell Heterogeneity Shaped by Alternative Splicing Predicts Prognosis in Hepatocellular Carcinoma
by: Xiaohui Peng, et al.
Published: (2026)
by: Xiaohui Peng, et al.
Published: (2026)
"The Prognosis, Doctor?"
by: Everhart, Nancy
Published: (1998)
by: Everhart, Nancy
Published: (1998)
Decreased lncRNA TMEM51‐AS1 Facilitates TNBC Progression and Its Diagnostic Value of Recurrence with Preoperative DCE‐MRI Characteristics
by: Tian Song, et al.
Published: (2025)
by: Tian Song, et al.
Published: (2025)
Single‐cell transcriptome sequencing reveals SPP1‐CD44‐mediated macrophage–tumor cell interactions drive chemoresistance in TNBC
by: Fuzhong Liu, et al.
Published: (2024)
by: Fuzhong Liu, et al.
Published: (2024)
Cancer Type, Stage and Prognosis Assessment from Pathology Reports using LLMs
by: Saluja, Rachit, et al.
Published: (2025)
by: Saluja, Rachit, et al.
Published: (2025)
From Cells to Survival: Hierarchical Analysis of Cell Inter-Relations in Multiplex Microscopy for Lung Cancer Prognosis
by: Schüllerqvist, Olle Edgren, et al.
Published: (2025)
by: Schüllerqvist, Olle Edgren, et al.
Published: (2025)
A Supramolecular Nanoengine Generates Nanomechanical Force on Demand for Precise Cytosolic Delivery of Anti‐miRNAs and Synergistic TNBC Therapy
by: Yuxin Yang, et al.
Published: (2025)
by: Yuxin Yang, et al.
Published: (2025)
Risk Factors of Disseminated Tumor Cells in the Bone Marrow of Patients With Angioimmunoblastic T‐Cell Lymphoma and Their Impact on Prognosis
by: Dongyao Yan, et al.
Published: (2026)
by: Dongyao Yan, et al.
Published: (2026)
Treatment Regimens and Response Rates in Early TNBC: A Review of Real‐World Practice in the Second Decade of the 21st Century
by: Maria Eleni Hatzipanagiotou, et al.
Published: (2026)
by: Maria Eleni Hatzipanagiotou, et al.
Published: (2026)
Enhancing the Anticancer Efficacy of Polyphenols Through Lipid‐Based and Polymeric Nanoparticle Delivery Systems in Triple‐Negative Breast Cancer (TNBC)
by: Nooshin Goudarzi, et al.
Published: (2026)
by: Nooshin Goudarzi, et al.
Published: (2026)
Prognosis of Diffusely Infiltrative Esophageal Squamous Cell Carcinoma After Radical Esophagectomy
by: Masahiro Tamura, et al.
Published: (2025)
by: Masahiro Tamura, et al.
Published: (2025)
KIFC1 is Associated With Sarcomatoid Differentiation, Immune Response, and a Poor Prognosis in Clear Cell Renal Cell Carcinoma
by: Yoshinori Nakano, et al.
Published: (2026)
by: Yoshinori Nakano, et al.
Published: (2026)
CircCFL1 Promotes TNBC Stemness and Immunoescape via Deacetylation‐Mediated c‐Myc Deubiquitylation to Facilitate Mutant TP53 Transcription
by: Zekun Wang, et al.
Published: (2024)
by: Zekun Wang, et al.
Published: (2024)
CD44 and Snail1 Expression Predicts Poor Prognosis of Oral Squamous Cell Carcinoma
by: Cintia Eliza Marques, et al.
Published: (2025)
by: Cintia Eliza Marques, et al.
Published: (2025)
Pharmacological Dissection Identifies Retatrutide Overcomes the Therapeutic Barrier of Obese TNBC Treatments through Suppressing the Interplay between Glycosylation and Ubiquitylation of YAP
by: Xin Cui, et al.
Published: (2025)
by: Xin Cui, et al.
Published: (2025)
Multifunctional Biomimetic Liposomes with Improved Tumor‐Targeting for TNBC Treatment by Combination of Chemotherapy, Antiangiogenesis and Immunotherapy (Adv. Healthcare Mater. 26/2024)
by: Jinshuai Lan, et al.
Published: (2024)
by: Jinshuai Lan, et al.
Published: (2024)
Similar Items
-
Ribosomal activation in TNBC resistance in vitro.
by: Mamoor, Shahan
Published: (2025) -
Raw read count lncRNA sequencing TNBC
by: van den Ende, Nadine, et al.
Published: (2026) -
Targeting NgR1/NogoA Signalling Enhances Natural Killer Cell Cytotoxicity and Alters Immune and Oncogenic Pathways in TNBC Cells
by: Tuğcan Korak, et al.
Published: (2026) -
Investigation of TNBC metastatic potential following synergistic photodynamic therapy and chemotherapy
by: Jeanne Duong, et al.
Published: (2025) -
Unraveling the Complexities in TNBC Gene Interaction Networks Towards Better Therapeutics
by: Priyanga Paranthaman, et al.
Published: (2025)